Cervical cancer is the second most common malignancy in women worldwide. Two HPV
strains, HPV-16 and 18, occur in the 70% of untreated cancers. Expression of viral …

Cervical cancer is an attractive model in which to test gene-specific therapies because
elimination of the human papillomavirus oncogenes, E6 and E7, results in cancer cell death …

Cervical cancer is the second most common cause of cancer death in women worldwide
and the development of new diagnosis, prognostic, and treatment strategies merits special …

Cervical cancer is the third most common cancer among women worldwide and is
responsible for 275.000 deaths each year. The development of cervical cancer has been …

It is well-known that the human papillomavirus (HPV) is the causative agent of cervical
cancer. The integration of HPV genes into the host genome causes the upregulation of E6 …

Highlights•Human papillomavirus (HPV) has a primordial role in the development of cervical
cancer.•Therapies currently available for cervical cancer treatment are reviewed.•The …

Cervical cancer continues to be a major worldwide health concern, particularly in
developing countries. In the past few decades, great strides have been made in …

Cervical cancer is a potentially preventable disease; however, it remains the second most
common malignancy in women worldwide. The human papillomavirus (HPV) is the single …

Cervical cancer is the fourth most common cancer among women. Infection by high-risk
human papillomavirus (HPV) is the main aetiology for the development of cervical cancer …

Introduction: Worldwide, most cervical cancer (CC) patients require the use of drug therapy
either adjuvant, concurrent with radiation or palliative. Areas covered: This review briefly …